Maricer P. Escalón

Prognostic factors and treatment of patients with T‐cell non‐Hodgkin lymphoma

Maricer P. Escalón, Nina S. Liu, Ying Yang et al. · Cancer · 2005 · 225 citations · Full text

Medicine, Oncology, Chemotherapy +12

Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft‐<i>versus</i>‐host disease

Daniel R. Couriel, Rima M. Saliba, Maricer P. Escalón et al. · British Journal of Haematology · 2005 · 184 citations

Life Sciences, Immunology, Pharmacotherapy +13

High incidence of false-positive PET scans in patients with aggressive non-Hodgkin’s lymphoma treated with rituximab-containing regimens

Hyo S. Han, Maricer P. Escalón, Bernard Hsiao et al. · Annals of Oncology · 2008 · 155 citations · Full text

Medicine, Oncology, Radiology +11

Nonmyeloablative Allogeneic Hematopoietic Transplantation: A Promising Salvage Therapy for Patients With Non-Hodgkin's Lymphoma Whose Disease Has Failed a Prior Autologous Transplantation

Maricer P. Escalón, Richard E. Champlin, Rima M. Saliba et al. · Journal of Clinical Oncology · 2004 · 109 citations

Medicine, Immunology, Oncology +13

LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in Obese Adults With Modest Hypertriglyceridemia

Daniel J. Rader, Eleftheria Maratos–Flier, A. Nguyen et al. · The Journal of Clinical Endocrinology & Metabolism · 2021 · 65 citations · Full text

Agriculture, Endocrinology, Pharmacotherapy +16